Matica Biotechnology and NCTM Forge Partnership to Support Cell and Gene Therapy Innovation
Matica Biotechnology, a leading CDMO specializing in cell and gene therapies (CGT), has announced a strategic partnership with the National Center for Therapeutics Manufacturing (NCTM), a part of the Texas A&M Engineering Experiment Station. This collaboration is designed to deliver a fully integrated service platform that supports CGT developers at every stage—from early research and IND-enabling studies to clinical trials and eventual commercialization.